Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy

博士 === 義守大學 === 化學工程學系暨生物技術與化學工程研究所 === 105

Bibliographic Details
Main Authors:	Hsien Liu, 劉憲
Other Authors:	Shih-Han Wang
Format:	Others
Language:	en_US
Published:	2017
Online Access:	http://ndltd.ncl.edu.tw/handle/5gs9a6

id	ndltd-TW-105ISU05063001
record_format	oai_dc
spelling	ndltd-TW-105ISU050630012019-05-15T23:39:16Z http://ndltd.ncl.edu.tw/handle/5gs9a6 Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy 經由雙磷酸鹽(Zoledronate)作用於調節性T細胞:一種嶄新的腫瘤免疫治療方式 Hsien Liu 劉憲博士義守大學化學工程學系暨生物技術與化學工程研究所 105 Shih-Han Wang Tsun-Mei Lin 王詩涵林尊湄 2017 學位論文 ; thesis 131 en_US
collection	NDLTD
language	en_US
format	Others
sources	NDLTD
description	博士 === 義守大學 === 化學工程學系暨生物技術與化學工程研究所 === 105
author2	Shih-Han Wang
author_facet	Shih-Han Wang Hsien Liu 劉憲
author	Hsien Liu 劉憲
spellingShingle	Hsien Liu 劉憲 Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy
author_sort	Hsien Liu
title	Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy
title_short	Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy
title_full	Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy
title_fullStr	Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy
title_full_unstemmed	Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy
title_sort	targeting the regulatory t cells by zoledronate as a novel therapeutic approach in cancer immunotherapy
publishDate	2017
url	http://ndltd.ncl.edu.tw/handle/5gs9a6
work_keys_str_mv	AT hsienliu targetingtheregulatorytcellsbyzoledronateasanoveltherapeuticapproachincancerimmunotherapy AT liúxiàn targetingtheregulatorytcellsbyzoledronateasanoveltherapeuticapproachincancerimmunotherapy AT hsienliu jīngyóushuānglínsuānyánzoledronatezuòyòngyúdiàojiéxìngtxìbāoyīzhǒngzhǎnxīndezhǒngliúmiǎnyìzhìliáofāngshì AT liúxiàn jīngyóushuānglínsuānyánzoledronatezuòyòngyúdiàojiéxìngtxìbāoyīzhǒngzhǎnxīndezhǒngliúmiǎnyìzhìliáofāngshì
_version_	1719150705186439168

Targeting the regulatory T cells by Zoledronate as a novel therapeutic approach in cancer immunotherapy

Similar Items